Literature DB >> 18420272

Contribution of the apparent diffusion coefficient in perilesional edema for the assessment of brain tumors.

R Guzman1, S Altrichter, M El-Koussy, J Gralla, J Weis, A Barth, R W Seiler, G Schroth, K O Lövblad.   

Abstract

OBJECTIVES: Diffusion-weighted MRI is sensitive to molecular motion and has been applied to the diagnosis of stroke. Our intention was to investigate its usefulness in patients with brain tumor and, in particular, in the perilesional edema.
METHODS: We performed MRI of the brain, including diffusion-weighted imaging and mapping of the apparent diffusion coefficient (ADC), in 16 patients with brain tumors (glioblastomas, low-grade gliomas and metastases). ADC values were determined by the use of regions of interest positioned in areas of high signal intensities as seen on T2-weighted images and ADC maps. Measurements were taken in the tumor itself, in the area of perilesional edema and in the healthy contralateral brain.
RESULTS: ADC mapping showed higher values of peritumoral edema in patients with glioblastoma (1.75 x 10(-3)mm(2)/s) and metastatic lesions (1.61 x 10(-3)mm(2)/s) compared with those who had low-grade glioma (1.40 x10(-3)mm(2)/s). The higher ADC values in the peritumoral zone were associated with lower ADC values in the tumor itself.
CONCLUSIONS: The higher ADC values in the more malignant tumors probably reflect vasogenic edema, thereby allowing their differentiation from other lesions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18420272     DOI: 10.1016/j.neurad.2008.02.003

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  9 in total

1.  ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.

Authors:  Martha Nowosielski; Wolfgang Recheis; Georg Goebel; Ozgür Güler; Gerd Tinkhauser; Herwig Kostron; Michael Schocke; Thaddaeus Gotwald; Günther Stockhammer; Markus Hutterer
Journal:  Neuroradiology       Date:  2010-12-02       Impact factor: 2.804

2.  Texture analysis of diffusion weighted imaging for the evaluation of glioma heterogeneity based on different regions of interest.

Authors:  Shan Wang; Meng Meng; Xue Zhang; Chen Wu; Ru Wang; Jiangfen Wu; Muhammad Umair Sami; Kai Xu
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

3.  Demonstration of DCE-MRI as an early pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.

Authors:  Allison F O'Neill; Lei Qin; Patrick Y Wen; John F de Groot; Annick D Van den Abbeele; Jeffrey T Yap
Journal:  J Neurooncol       Date:  2016-08-30       Impact factor: 4.130

Review 4.  Advanced magnetic resonance imaging biomarkers of cerebral metastases.

Authors:  S J Mills; G Thompson; A Jackson
Journal:  Cancer Imaging       Date:  2012-08-10       Impact factor: 3.909

5.  Brain Tumor Characterization Using Multibiometric Evaluation of MRI.

Authors:  Faris Durmo; Jimmy Lätt; Anna Rydelius; Silke Engelholm; Sara Kinhult; Krister Askaner; Elisabet Englund; Johan Bengzon; Markus Nilsson; Isabella M Björkman-Burtscher; Thomas Chenevert; Linda Knutsson; Pia C Sundgren
Journal:  Tomography       Date:  2018-03

Review 6.  Clinical applications of diffusion weighted imaging in neuroradiology.

Authors:  Marta Drake-Pérez; Jose Boto; Aikaterini Fitsiori; Karl Lovblad; Maria Isabel Vargas
Journal:  Insights Imaging       Date:  2018-05-30

Review 7.  Blood-Brain Barrier Alterations and Edema Formation in Different Brain Mass Lesions.

Authors:  Peter Solar; Michal Hendrych; Martin Barak; Hana Valekova; Marketa Hermanova; Radim Jancalek
Journal:  Front Cell Neurosci       Date:  2022-07-15       Impact factor: 6.147

8.  Evaluation of Perienhancing Area in Differentiation between Glioblastoma and Solitary Brain Metastasis.

Authors:  Jureerat Thammaroj; Nattha Wongwichit; Arunnit Boonrod
Journal:  Asian Pac J Cancer Prev       Date:  2020-09-01

9.  Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging.

Authors:  Johann-Martin Hempel; Cornelia Brendle; Sasan Darius Adib; Felix Behling; Ghazaleh Tabatabai; Salvador Castaneda Vega; Jens Schittenhelm; Ulrike Ernemann; Uwe Klose
Journal:  J Clin Med       Date:  2021-05-26       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.